Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880410 · ClinicalTrials.gov registry record · Phase 1
Feasibility Study on LITT for Newly Diagnosed Glioblastoma
A Phase 1 study, sponsored by Monteris Medical.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02880410 is a Phase 1 study that was terminated before completion, run by Monteris Medical. The registered enrollment target is 3 participants.
The verdict
NCT02880410, a Phase 1 study, was terminated before completion, sponsored by Monteris Medical.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in combination with standard of care radiation therapy and temozolomide for the treatment of newly diagnosed glioblastomas (GBM).
Interventions
- DEVICE NeuroBlate System
- DRUG Radiation therapy and temozolomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2018-09-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02880410
The ClinicalTrials.gov registry entry for NCT02880410 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monteris Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NeuroBlate System is the first listed.
NCT02880410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02880410 about?
NCT02880410 is a clinical study titled "Feasibility Study on LITT for Newly Diagnosed Glioblastoma". Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in combination with standard of care radiation therapy and temozolomide for the treatment of newly diagnosed glioblasto...
What is the current status of trial NCT02880410?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2017-08-15. Estimated completion is 2018-09-14.
What interventions are being tested in trial NCT02880410?
The interventions under investigation include: NeuroBlate System (DEVICE), Radiation therapy and temozolomide (DRUG).
Who is sponsoring clinical trial NCT02880410?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.